关于莫亚莫亚病的多学科研究:当前的观点和未来的方向
Qingbao Guo1, Na Li2
1Department of Neurosurgery, XI'AN NO.9 HOSPITAL, 151 East Section of South Second Ring Road, Xian, 710054, Shaanxi, China. guo18291908296@163.com.
Nutrition & metabolism
|December 7, 2025
概括
多omics揭示了莫亚莫亚病 (MMD) 的关键遗传和分子标记. 这种方法有助于了解MMD的发病因子,并开发个性化治疗方法,以改善患者的治疗结果.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 遗传学 是一个
- 生物化学 生物化学
背景情况:
- 莫亚莫亚病 (MMD) 是一种罕见的,进展性脑血管疾病.
- 其确切的发病因子尚未完全理解,需要进行先进的分子研究.
研究的目的:
- 在莫亚莫亚病研究中探索多奥米克技术的应用和进展.
- 讨论OMIC方法在MMD分析,预防和治疗中的优缺点.
主要方法:
- 基因组研究确定易感点 (例如,RNF213 p.R4810K).
- 转录组,蛋白组,代谢组和表观组分析以确定分子标记物.
- 整合多主题数据,以全面理解.
主要成果:
- 显著的遗传关联 (RNF213,HLA-DQA2,GUCY1A3) 和分子标记 (AQP4,miR-107,VEGF,氨基酸,LPC16:1) 的发现.
- 在细胞外基质的调节失调,氧化酸化和铁亡途径被确定.
- 与MMD相关的SOX6和KCNMA1的表观基因组变化.
结论:
- 多omics方法为MMD病原体提供了关键的分子洞察力.
- 这些发现支持开发精准医学策略,包括向治疗和个性化干预.
- Omics数据可以指导MMD的未来研究和临床决策.
相关概念视频
Genomics
39.6K
Genomics is the science of genomes: it is the study of all the genetic material of an organism. In humans, the genome consists of information carried in 23 pairs of chromosomes in the nucleus, as well as mitochondrial DNA. In genomics, both coding and non-coding DNA is sequenced and analyzed. Genomics allows a better understanding of all living things, their evolution, and their diversity. It has a myriad of uses: for example, to build phylogenetic trees, to improve productivity and...
39.6K
Ischemic Heart Disease: Overview
2.8K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
2.8K
Coronary Artery Disease II: Pathophysiology
342
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
342
Atherosclerosis III: Management
296
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
296
Coronary Artery Disease I: Introduction
850
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
850
Combination Therapies and Personalized Medicine
5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K


